Ajanta Pharma Limited (NSE: AJANTPHARM)
3,350.35
+20.25 (0.61%)
Sep 6, 2024, 3:30 PM IST
Ajanta Pharma Revenue
Ajanta Pharma had revenue of 11.45B INR in the quarter ending June 30, 2024, with 12.13% growth. This brings the company's revenue in the last twelve months to 43.33B, up 13.63% year-over-year. In the fiscal year ending March 31, 2024, Ajanta Pharma had annual revenue of 42.09B with 12.45% growth.
Revenue (ttm)
43.33B
Revenue Growth
+13.63%
P/S Ratio
9.73
Revenue / Employee
5.37M
Employees
8,073
Market Cap
419.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 42.09B | 4.66B | 12.45% |
Mar 31, 2023 | 37.43B | 4.02B | 12.02% |
Mar 31, 2022 | 33.41B | 4.51B | 15.62% |
Mar 31, 2021 | 28.90B | 3.02B | 11.66% |
Mar 31, 2020 | 25.88B | 5.33B | 25.91% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries Limited | 9,252.89B |
Tata Consultancy Services Limited | 2,441.25B |
HDFC Bank Limited | 2,663.37B |
Bharti Airtel Limited | 1,510.49B |
ICICI Bank Limited | 1,686.78B |
Infosys Limited | 1,555.41B |
State Bank of India | 3,319.63B |
Hindustan Unilever Limited | 621.07B |